Pavenstädt HJ - Search Results

1

Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinoma.

Schelleckes K, Schmitz B, Ciarimboli G, Lenders M, Pavenstädt HJ, Herrmann E, Brand SM, Brand E. Schelleckes K, et al. Among authors: pavenstadt hj. Clin Epigenetics. 2017 Oct 6;9:109. doi: 10.1186/s13148-017-0415-6. eCollection 2017. Clin Epigenetics. 2017. PMID: 29046731 Free PMC article.

2

Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2.

Ciarimboli G, Ludwig T, Lang D, Pavenstädt H, Koepsell H, Piechota HJ, Haier J, Jaehde U, Zisowsky J, Schlatter E. Ciarimboli G, et al. Among authors: pavenstadt h. Am J Pathol. 2005 Dec;167(6):1477-84. doi: 10.1016/S0002-9440(10)61234-5. Am J Pathol. 2005. PMID: 16314463 Free PMC article.

3

Temporal-spatial expression and novel biochemical properties of the memory-related protein KIBRA.

Johannsen S, Duning K, Pavenstädt H, Kremerskothen J, Boeckers TM. Johannsen S, et al. Neuroscience. 2008 Sep 9;155(4):1165-73. doi: 10.1016/j.neuroscience.2008.06.054. Epub 2008 Jul 3. Neuroscience. 2008. PMID: 18672031

4

Dilemmas in the management of atrial fibrillation in chronic kidney disease.

Reinecke H, Brand E, Mesters R, Schäbitz WR, Fisher M, Pavenstädt H, Breithardt G. Reinecke H, et al. J Am Soc Nephrol. 2009 Apr;20(4):705-11. doi: 10.1681/ASN.2007111207. Epub 2008 Dec 17. J Am Soc Nephrol. 2009. PMID: 19092127 Review.

5

Molecular genetic analysis of a human insulin-like growth factor 1 promoter P1 variation.

Telgmann R, Dördelmann C, Brand E, Nicaud V, Hagedorn C, Pavenstädt H, Cambien F, Tiret L, Paul M, Brand-Herrmann SM. Telgmann R, et al. FASEB J. 2009 May;23(5):1303-13. doi: 10.1096/fj.08-116863. Epub 2008 Dec 22. FASEB J. 2009. PMID: 19103645

6

The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD.

Di Marco GS, Reuter S, Hillebrand U, Amler S, König M, Larger E, Oberleithner H, Brand E, Pavenstädt H, Brand M. Di Marco GS, et al. J Am Soc Nephrol. 2009 Oct;20(10):2235-45. doi: 10.1681/ASN.2009010061. Epub 2009 Jul 16. J Am Soc Nephrol. 2009. PMID: 19608702 Free PMC article.

7

Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions.

Ciarimboli G, Deuster D, Knief A, Sperling M, Holtkamp M, Edemir B, Pavenstädt H, Lanvers-Kaminsky C, am Zehnhoff-Dinnesen A, Schinkel AH, Koepsell H, Jürgens H, Schlatter E. Ciarimboli G, et al. Am J Pathol. 2010 Mar;176(3):1169-80. doi: 10.2353/ajpath.2010.090610. Epub 2010 Jan 28. Am J Pathol. 2010. PMID: 20110413 Free PMC article.

8

New clues for nephrotoxicity induced by ifosfamide: preferential renal uptake via the human organic cation transporter 2.

Ciarimboli G, Holle SK, Vollenbröcker B, Hagos Y, Reuter S, Burckhardt G, Bierer S, Herrmann E, Pavenstädt H, Rossi R, Kleta R, Schlatter E. Ciarimboli G, et al. Mol Pharm. 2011 Feb 7;8(1):270-9. doi: 10.1021/mp100329u. Epub 2010 Dec 2. Mol Pharm. 2011. PMID: 21077648

9

C-reactive protein makes human endothelium stiff and tight.

Kusche-Vihrog K, Urbanova K, Blanqué A, Wilhelmi M, Schillers H, Kliche K, Pavenstädt H, Brand E, Oberleithner H. Kusche-Vihrog K, et al. Hypertension. 2011 Feb;57(2):231-7. doi: 10.1161/HYPERTENSIONAHA.110.163444. Epub 2010 Dec 13. Hypertension. 2011. PMID: 21149827

10

Properties and regulation of organic cation transport in freshly isolated mouse proximal tubules analyzed with a fluorescence reader-based method.

Holle SK, Ciarimboli G, Edemir B, Neugebauer U, Pavenstädt H, Schlatter E. Holle SK, et al. Pflugers Arch. 2011 Aug;462(2):359-69. doi: 10.1007/s00424-011-0969-7. Epub 2011 Apr 27. Pflugers Arch. 2011. PMID: 21523352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

317 results

Search Page